Abstract
Substantial progress in aging research continues to deepen our understanding of the fundamental mechanisms of aging, yet there is a lack of interventions conclusively shown to attenuate the processes of aging in humans. By contrast, replacement interventions such as joint replacements, pacemaker devices and transplant therapies have a long history of restoring function in injury or disease contexts. Here, we consider biological and synthetic replacement-based strategies as aging interventions. We discuss innovations in tissue engineering, such as the use of scaffolds or bioprinting to generate functional tissues, methods for enhancing donor–recipient compatibility through genetic engineering and recent progress in both cell therapies and xenotransplantation strategies. We explore synthetic approaches including prostheses, external devices and brain–machine interfaces. Additionally, we evaluate the evidence from heterochronic parabiosis experiments in mice and donor–recipient age-mismatched transplants to consider whether systemic benefits could result from personalized replacement approaches. Finally, we outline key challenges and future directions required to advance replacement therapies as viable, scalable and ethical interventions for aging.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243–278 (2023).
Campisi, J. et al. From discoveries in ageing research to therapeutics for healthy ageing. Nature 571, 183–192 (2019).
Kelley, A. et al. National Institute on Aging’s 50th anniversary: advancing aging research and the health and well-being of older adults. J. Am. Geriatr. Soc. 72, 1574–1582 (2024).
Gladyshev, V. N. et al. Molecular damage in aging. Nat. Aging 1, 1096–1106 (2021).
Thurston, A. J. Paré and prosthetics: the early history of artificial limbs. ANZ J. Surg. 77, 1114–1119 (2007).
Pollington, S. & van Noort, R. An update of ceramics in dentistry. Int. J. Clin. Dent. 2, 283 (2009).
Atchison, D. A. & Thibos, L. N. Optical models of the human eye. Clin. Exp. Optom. 99, 99–106 (2016).
Valentinuzzi, M. E. Hearing aid history: from ear trumpets to digital technology. IEEE Pulse 11, 33–36 (2020).
Fastag, E., Varon, J. & Sternbach, G. Richard Lower: the origins of blood transfusion. J. Emerg. Med. 44, 1146–1150 (2013).
Moffatt, S. L., Cartwright, V. A. & Stumpf, T. H. Centennial review of corneal transplantation. Clin. Exp. Ophthalmol. 33, 642–657 (2005).
Lugli, T. Artificial shoulder joint by Péan (1893): the facts of an exceptional intervention and the prosthetic method. Clin. Orthop. Relat. Res. 215–218 (1978).
Cingolani, E., Goldhaber, J. I. & Marbán, E. Next-generation pacemakers: from small devices to biological pacemakers. Nat. Rev. Cardiol. 15, 139–150 (2018).
Gottschalk, C. W. & Fellner, S. K. History of the science of dialysis. Am. J. Nephrol. 17, 289–298 (1997).
Simpson, E. & Dazzi, F. Bone marrow transplantation 1957–2019. Front. Immunol. 10, 1246 (2019).
Murphy, S. V. & Atala, A. Organ engineering — combining stem cells, biomaterials, and bioreactors to produce bioengineered organs for transplantation. BioEssays 35, 163–172 (2013).
Spardy, J. et al. National analysis of recent trends in organ donation and transplantation in the United States: toward optimizing care delivery and patient outcomes. Am. Surg. 89, 5201–5209 (2023).
Tullius, S. G. et al. The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. Ann. Surg. 252, 662–674 (2010).
Grazi, G. L. et al. A revised consideration on the use of very aged donors for liver transplantation. Am. J. Transpl. 1, 61–68 (2001).
López-Vilella, R., Donoso Trenado, V., Sánchez-Lázaro, I., Martínez-Dolz, L. & Almenar-Bonet, L. Analysis of heart transplant survival according to difference in age between donor and recipient. Transplant. Proc. 54, 2503–2505 (2022).
Snyder, A. et al. Evaluating the outcomes of donor–recipient age differences in young adults undergoing liver transplantation. Liver Transplant. 29, 793–803 (2023).
Pippias, M. et al. Young deceased donor kidneys show a survival benefit over older donor kidneys in transplant recipients aged 20–50 years: a study by the ERA–EDTA Registry. Nephrol. Dial. Transplant. 35, 534–543 (2020).
Rebo, J. et al. A single heterochronic blood exchange reveals rapid inhibition of multiple tissues by old blood. Nat. Commun. 7, 13363 (2016).
Villeda, S. A. et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90–94 (2011).
Conboy, I. M. & Rando, T. A. Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches. Cell Cycle 11, 2260–2267 (2012).
Carlson, B. M. & Faulkner, J. A. Muscle transplantation between young and old rats: age of host determines recovery. Am. J. Physiol. 256, C1262–C1266 (1989).
Zhang, B. et al. Multi-omic rejuvenation and lifespan extension on exposure to youthful circulation. Nat. Aging 3, 948–964 (2023).
Conboy, I. M. et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433, 760–764 (2005).
Conboy, I. M. & Rando, T. A. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 3, 397–409 (2002).
Ruckh, J. M. et al. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10, 96–103 (2012).
Loffredo, F. S. et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153, 828–839 (2013).
Middeldorp, J. et al. Preclinical assessment of young blood plasma for Alzheimer disease. JAMA Neurol. 73, 1325–1333 (2016).
Liu, Z. et al. Underlying features of epigenetic aging clocks in vivo and in vitro. Aging Cell 19, e13229 (2020).
US FDA. Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions. FDA www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-and-director-fdas-center-biologics-evaluation-and-0 (2020).
Fuentealba, M. et al. Multi-omics analysis reveals biomarkers that contribute to biological age rejuvenation in response to therapeutic plasma exchange. Preprint at medRxiv https://doi.org/10.1101/2024.08.02.24310303 (2024).
Katabathina, V., Menias, C. O., Pickhardt, P., Lubner, M. & Prasad, S. R. Complications of immunosuppressive therapy in solid organ transplantation. Radiol. Clin. North Am. 54, 303–319 (2016).
Shlomchik, W. D. Graft-versus-host disease. Nat. Rev. Immunol. 7, 340–352 (2007).
Dörje, C. et al. Early versus late acute antibody-mediated rejection in renal transplant recipients. Transplantation 96, 79–84 (2013).
Hostetter, T. H. Chronic transplant rejection. Kidney Int. 46, 266–279 (1994).
Lodhi, S. A., Lamb, K. E. & Meier-Kriesche, H. U. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am. J. Transplant. 11, 1226–1235 (2011).
Italia, J. L., Bhardwaj, V. & Kumar, M. N. V. R. Disease, destination, dose and delivery aspects of ciclosporin: the state of the art. Drug Discov. Today 11, 846–854 (2006).
Montgomery, R. A., Tatapudi, V. S., Leffell, M. S. & Zachary, A. A. HLA in transplantation. Nat. Rev. Nephrol. 14, 558–570 (2018).
Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).
Oh, H. S.-H. et al. Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164–172 (2023).
Picollet-D’hahan, N., Zuchowska, A., Lemeunier, I. & Gac, S. L. Multiorgan-on-a-chip: a systemic approach to model and decipher inter-organ communication. Trends Biotechnol. 39, 788–810 (2021).
Girousse, A. et al. Endogenous mobilization of mesenchymal stromal cells: a pathway for interorgan communication? Front. Cell Dev. Biol. 8, 598520 (2021).
Goeminne, L. J. E. et al. Plasma protein-based organ-specific aging and mortality models unveil diseases as accelerated aging of organismal systems. Cell Metab. 37, 205–222 (2025).
Correia Carreira, S., Begum, R. & Perriman, A. W. 3D bioprinting: the emergence of programmable biodesign. Adv. Healthc. Mater. 9, e1900554 (2020).
Saad, A. et al. Hematopoietic cell transplantation, version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J. Natl Compr. Canc. Netw. 18, 599–634 (2020).
Bouton, C. E. et al. Restoring cortical control of functional movement in a human with quadriplegia. Nature 533, 247–250 (2016).
Tan, X., Qiu, L.-L. & Sun, J. Research progress on the role of inflammatory mechanisms in the development of postoperative cognitive dysfunction. BioMed. Res. Int. 2021, 3883204 (2021).
Ward, M. et al. Successful aging after elective surgery II: study cohort description. J. Am. Geriatr. Soc. 72, 209–218 (2024).
Rickels, M. R. & Robertson, R. P. Pancreatic islet transplantation in humans: recent progress and future directions. Endocr. Rev. 40, 631–668 (2019).
Iansante, V., Mitry, R. R., Filippi, C., Fitzpatrick, E. & Dhawan, A. Human hepatocyte transplantation for liver disease: current status and future perspectives. Pediatr. Res. 83, 232–240 (2018).
Baker, D. J., Arany, Z., Baur, J. A., Epstein, J. A. & June, C. H. CAR T therapy beyond cancer: the evolution of a living drug. Nature 619, 707–715 (2023).
Buedo, P., Bianchini, A., Klas, K. & Waligora, M. Bioethics of somatic gene therapy: what do we know so far? Curr. Med. Res. Opin. 39, 1355–1365 (2023).
Rohde, M. et al. Practical and statistical considerations for the long term follow-up of gene therapy trial participants. Clin. Pharmacol. Ther. 115, 139–146 (2024).
Arnold, S. D., Bhatia, M., Horan, J. & Krishnamurti, L. Haematopoietic stem cell transplantation for sickle cell disease — current practice and new approaches. Br. J. Haematol. 174, 515–525 (2016).
Swart, J. F. et al. Haematopoietic stem cell transplantation for autoimmune diseases. Nat. Rev. Rheumatol. 13, 244–256 (2017).
Ferrari, G., Thrasher, A. J. & Aiuti, A. Gene therapy using haematopoietic stem and progenitor cells. Nat. Rev. Genet. 22, 216–234 (2021).
George, B. M. et al. Antibody conditioning enables MHC-mismatched hematopoietic stem cell transplants and organ graft tolerance. Cell Stem Cell 25, 185–192 (2019).
Brunet, A., Goodell, M. A. & Rando, T. A. Ageing and rejuvenation of tissue stem cells and their niches. Nat. Rev. Mol. Cell Biol. 24, 45–62 (2023).
Liu, H. et al. Advances in retinal pigment epithelial cell transplantation for retinal degenerative diseases. Stem Cell Res. Ther. 15, 390 (2024).
Copp, G., Robb, K. P. & Viswanathan, S. Culture-expanded mesenchymal stromal cell therapy: does it work in knee osteoarthritis? A pathway to clinical success. Cell. Mol. Immunol. 20, 626–650 (2023).
Lin, Y.-H., Lehle, J. D. & McCarrey, J. R. Source cell-type epigenetic memory persists in induced pluripotent cells but is lost in subsequently derived germline cells. Front. Cell Dev. Biol. 12, 1306530 (2024).
Tarazi, S. et al. Post-gastrulation synthetic embryos generated ex utero from mouse naive ESCs. Cell 185, 3290–3306 (2022).
Oldak, B. et al. Complete human day 14 post-implantation embryo models from naive ES cells. Nature 622, 562–573 (2023).
Godlewski, G., Gaubert-Cristol, R., Rouy, S. & Prudhomme, M. Liver development in the rat and in man during the embryonic period (Carnegie stages 11–23). Microsc. Res. Tech. 39, 314–327 (1997).
Julien, E., El Omar, R. & Tavian, M. Origin of the hematopoietic system in the human embryo. FEBS Lett. 590, 3987–4001 (2016).
Rengaraj, D. & Han, J. Y. Female germ cell development in chickens and humans: the chicken oocyte enriched genes convergent and divergent with the human oocyte. Int. J. Mol. Sci. 23, 11412 (2022).
Piper, K. et al. Beta cell differentiation during early human pancreas development. J. Endocrinol. 181, 11–23 (2004).
Parums, D. V. Editorial: first regulatory approval for allogeneic pancreatic islet beta cell infusion for adult patients with type 1 diabetes mellitus. Med. Sci. Monit. 29, e941918 (2023).
Abken, H. Building on synthetic immunology and T cell engineering: a brief journey through the history of chimeric antigen receptors. Hum. Gene Ther. 32, 1011–1028 (2021).
Schett, G. et al. Advancements and challenges in CAR T cell therapy in autoimmune diseases. Nat. Rev. Rheumatol. 20, 531–544 (2024).
Matai, I., Kaur, G., Seyedsalehi, A., McClinton, A. & Laurencin, C. T. Progress in 3D bioprinting technology for tissue/organ regenerative engineering. Biomaterials 226, 119536 (2020).
Atala, A., Bauer, S. B., Soker, S., Yoo, J. J. & Retik, A. B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367, 1241–1246 (2006).
Oberpenning, F., Meng, J., Yoo, J. J. & Atala, A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat. Biotechnol. 17, 149–155 (1999).
Raya-Rivera, A. et al. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet 377, 1175–1182 (2011).
Raya-Rivera, A. M. et al. Tissue-engineered autologous vaginal organs in patients: a pilot cohort study. Lancet 384, 329–336 (2014).
Kang, H.-W. et al. A 3D bioprinting system to produce human-scale tissue constructs with structural integrity. Nat. Biotechnol. 34, 312–319 (2016).
MacNeil, S. Progress and opportunities for tissue-engineered skin. Nature 445, 874–880 (2007).
Poghosyan, T. et al. Esophageal tissue engineering: current status and perspectives. J. Visc. Surg. 153, 21–29 (2016).
Bertassoni, L. E. Bioprinting of complex multicellular organs with advanced functionality—recent progress and challenges ahead. Adv. Mater. 34, e2101321 (2022).
Wolf, K. J., Weiss, J. D., Uzel, S. G. M., Skylar-Scott, M. A. & Lewis, J. A. Biomanufacturing human tissues via organ building blocks. Cell Stem Cell 29, 667–677 (2022).
Skylar-Scott, M. A. et al. Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels. Sci. Adv. 5, eaaw2459 (2019).
Bejleri, D. et al. A bioprinted cardiac patch composed of cardiac-specific extracellular matrix and progenitor cells for heart repair. Adv. Healthc. Mater. 7, 1800672 (2018).
Sarkar, N., Bhumiratana, S., Geris, L., Papantoniou, I. & Grayson, W. L. Bioreactors for engineering patient-specific tissue grafts. Nat. Rev. Bioeng. 1, 361–377 (2023).
Dorling, A., Riesbeck, K., Warrens, A. & Lechler, R. Clinical xenotransplantation of solid organs. Lancet 349, 867–871 (1997).
Anand, R. P. et al. Design and testing of a humanized porcine donor for xenotransplantation. Nature 622, 393–401 (2023).
Montgomery, R. A. et al. Results of two cases of pig-to-human kidney xenotransplantation. N. Engl. J. Med. 386, 1889–1898 (2022).
Yamamoto, T. et al. Life-supporting kidney xenotransplantation from genetically engineered pigs in baboons: a comparison of two immunosuppressive regimens. Transplantation 103, 2090–2104 (2019).
Eisenson, D. et al. Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs. Nat. Commun. 15, 3361 (2024).
Kozlov, M. Pig-organ transplants: what three human recipients have taught scientists. Nature 629, 980–981 (2024).
Längin, M. et al. Consistent success in life-supporting porcine cardiac xenotransplantation. Nature 564, 430–433 (2018).
Moazami, N. et al. Pig-to-human heart xenotransplantation in two recently deceased human recipients. Nat. Med. 29, 1989–1997 (2023).
Nishimura, T. et al. Generation of functional organs using a cell-competitive niche in intra- and inter-species rodent chimeras. Cell Stem Cell 28, 141–149 (2021).
Huang, J. et al. Generation of rat forebrain tissues in mice. Cell 187, 2129–2142 (2024).
Shawlot, W. & Behringer, R. R. Requirement for Lim1 in head-organizer function. Nature 374, 425–430 (1995).
Smith, K. et al. Hierarchical complexity of the adult human structural connectome. Neuroimage 191, 205–215 (2019).
van den Heuvel, M. P. & Sporns, O. Network hubs in the human brain. Trends Cogn. Sci. 17, 683–696 (2013).
Hebert, J. Replacing Aging (Science Unbound, 2020).
Hébert, J. M. Could an old brain be made young again? Surg. Neurol. Int. 13, 595 (2022).
Hébert, J. M. & Vijg, J. Cell replacement to reverse brain aging: challenges, pitfalls, and opportunities. Trends Neurosci. 41, 267–279 (2018).
Harary, P. M. et al. Cell replacement therapy for brain repair: recent progress and remaining challenges for treating Parkinson’s disease and cortical injury. Brain Sci. 13, 1654 (2023).
Babu, H. et al. First-in-human trial of NRTX-1001 GABAergic interneuron cell therapy for treatment of focal epilepsy — emerging clinical trial results (S19.002). Neurology 102, 5721 (2024).
McGinley, L. M. et al. Human neural stem cell transplantation improves cognition in a murine model of Alzheimer’s disease. Sci. Rep. 8, 14776 (2018).
McCaughey-Chapman, A. et al. Reprogrammed human lateral ganglionic eminence precursors generate striatal neurons and restore motor function in a rat model of Huntington’s disease. Stem Cell Res. Ther. 15, 448 (2024).
Sykova, E., Cizkova, D. & Kubinova, S. Mesenchymal stem cells in treatment of spinal cord injury and amyotrophic lateral sclerosis. Front. Cell Dev. Biol. 9, 695900 (2021).
Falkner, S. et al. Transplanted embryonic neurons integrate into adult neocortical circuits. Nature 539, 248–253 (2016).
Revah, O. et al. Maturation and circuit integration of transplanted human cortical organoids. Nature 610, 319–326 (2022).
Quezada, A. et al. An in vivo platform for rebuilding functional neocortical tissue. Bioengineering 10, 263 (2023).
Rosenzweig, S. & Carmichael, S. T. The axon–glia unit in white matter stroke: mechanisms of damage and recovery. Brain Res. 1623, 123–134 (2015).
Ashrafian, H., Darzi, A. & Athanasiou, T. Autobionics: a new paradigm in regenerative medicine and surgery. Regen. Med. 5, 279–288 (2010).
Willsey, M. S. et al. Real-time brain–machine interface in non-human primates achieves high-velocity prosthetic finger movements using a shallow feedforward neural network decoder. Nat. Commun. 13, 6899 (2022).
Ruetz, A. et al. A microprocessor stance and swing control orthosis improves balance, risk of falling, mobility, function, and quality of life of individuals dependent on a knee–ankle–foot orthosis for ambulation. Disabil. Rehabil. 46, 4019–4032 (2024).
Capsi-Morales, P. et al. Comparison between rigid and soft poly-articulated prosthetic hands in non-expert myo-electric users shows advantages of soft robotics. Sci. Rep. 11, 23952 (2021).
Tran, M., Gabert, L., Hood, S. & Lenzi, T. A lightweight robotic leg prosthesis replicating the biomechanics of the knee, ankle, and toe joint. Sci. Robot. 7, eabo3996 (2022).
Apple, D. J. & Sims, J. Harold Ridley and the invention of the intraocular lens. Surv. Ophthalmol. 40, 279–292 (1996).
Twomey-Kozak, J., Hurley, E., Levin, J., Anakwenze, O. & Klifto, C. Technological innovations in shoulder replacement: current concepts and the future of robotics in total shoulder arthroplasty. J. Shoulder Elbow Surg. 32, 2161–2171 (2023).
de Caxias, F. P., dos Santos, D. M., Bannwart, L. C., de Moraes Melo Neto, C. L. & Goiato, M. C. Classification, history, and future prospects of maxillofacial prosthesis. Int. J. Dent. 2019, 8657619 (2019).
Gallagher, P., Buckmaster, A., O’Carroll, S., Kiernan, G. & Geraghty, J. External breast prostheses in post-mastectomy care: women’s qualitative accounts. Eur. J. Cancer Care 19, 61–71 (2010).
Singh, S. K. et al. Polymeric prosthetic heart valves: a review of current technologies and future directions. Front. Cardiovasc. Med. 10, 1137827 (2023).
Roche, E. T. et al. Soft robotic sleeve supports heart function. Sci. Transl. Med. 9, eaaf3925 (2017).
Chonan, S. et al. Development of an artificial urethral valve using SMA actuators. Smart Mater. Struct. 6, 410–414 (1997).
Griffin, D. R. et al. Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing. Nat. Mater. 20, 560–569 (2021).
Cook, J. A. et al. The total artificial heart. J. Thorac. Dis. 7, 2172–2180 (2015).
Tang, D. G., Oyer, P. E. & Mallidi, H. R. Ventricular assist devices: history, patient selection, and timing of therapy. J. Cardiovasc. Transl. Res. 2, 159–167 (2009).
Marasco, S. F., Lukas, G., McDonald, M., McMillan, J. & Ihle, B. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ. 17, S41–S47 (2008).
Meyer, J. A. A practical mechanical respirator 1929: the “iron lung”. Ann. Thoracic Surgery 50, 490–493 (1990).
Chatburn, R. L. Understanding mechanical ventilators. Expert Rev. Respir. Med. 4, 809–819 (2010).
Forlenza, G. P., Buckingham, B. & Maahs, D. M. Progress in diabetes technology: developments in insulin pumps, continuous glucose monitors, and progress towards the artificial pancreas. J. Pediatr. 169, 13–20 (2016).
Salani, M., Roy, S. & Fissell, W. H. Innovations in wearable and implantable artificial kidneys. Am. J. Kidney Dis. 72, 745–751 (2018).
Krisper, P. & Stauber, R. E. Technology insight: artificial extracorporeal liver support—how does Prometheus® compare with MARS®? Nat. Clin. Pract. Nephrol. 3, 267–276 (2007).
Hessel, E. A. History of cardiopulmonary bypass (CPB). Best Pract. Res. Clin. Anaesthesiol. 29, 99–111 (2015).
Bensmaia, S. J. & Miller, L. E. Restoring sensorimotor function through intracortical interfaces: progress and looming challenges. Nat. Rev. Neurosci. 15, 313–325 (2014).
Fetz, E. E. Operant conditioning of cortical unit activity. Science 163, 955–958 (1969).
Chandrasekaran, S. et al. Historical perspectives, challenges, and future directions of implantable brain–computer interfaces for sensorimotor applications. Bioelectron. Med. 7, 14 (2021).
Hochberg, L. R. et al. Neuronal ensemble control of prosthetic devices by a human with tetraplegia. Nature 442, 164–171 (2006).
Mudry, A. & Mills, M. The early history of the cochlear implant: a retrospective. JAMA Otolaryngol. Head Neck Surg. 139, 446–453 (2013).
Greenemeier, L. FDA approves first retinal implant. Nature https://doi.org/10.1038/nature.2013.12439 (2013).
Gardner, J. A history of deep brain stimulation: technological innovation and the role of clinical assessment tools. Soc. Stud. Sci. 43, 707–728 (2013).
Griggs, W. S. et al. Decoding motor plans using a closed-loop ultrasonic brain–machine interface. Nat. Neurosci. 27, 196–207 (2024).
Jannati, A., Oberman, L. M., Rotenberg, A. & Pascual-Leone, A. Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation. Neuropsychopharmacology 48, 191–208 (2023).
Violante, I. R. et al. Non-invasive temporal interference electrical stimulation of the human hippocampus. Nat. Neurosci. 26, 1994–2004 (2023).
Lorach, H. et al. Walking naturally after spinal cord injury using a brain–spine interface. Nature 618, 126–133 (2023).
Dhillon, G. S., Lawrence, S. M., Hutchinson, D. T. & Horch, K. W. Residual function in peripheral nerve stumps of amputees: implications for neural control of artificial limbs. J. Hand Surgery 29, 605–615 (2004).
Mueller, T. F. & Nagral, S. Organ trafficking — a continuing challenge. Nat. Rev. Nephrol. 20, 267–268 (2024).
Matthews, K. R. & Moralí, D. National human embryo and embryoid research policies: a survey of 22 top research-intensive countries. Regen. Med. 15, 1905–1917 (2020).
Lopes, R. & Prasad, M. K. Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics. Front. Bioeng. Biotechnol. 11, 1339189 (2024).
Schlimgen, R. et al. Risks associated with lentiviral vector exposures and prevention strategies. J. Occup. Environ. Med. 58, 1159–1166 (2016).
Han, Z. et al. Vitrification and nanowarming enable long-term organ cryopreservation and life-sustaining kidney transplantation in a rat model. Nat. Commun. 14, 3407 (2023).
Vrselja, Z. et al. Restoration of brain circulation and cellular functions hours post-mortem. Nature 568, 336–343 (2019).
Grunhaus, L., Dannon, P. N. & Gershon, A. A. Transcranial magnetic stimulation: a new tool in the fight against depression. Dialogues Clin. Neurosci. 4, 93–103 (2002).
Acknowledgements
Figures 3–6 were created with or modified from BioRender.com. S.L. thanks R. Goodbar, S. Lore, M. van Kooten and A. Colville for their support throughout the preparation of this Perspective. Supported by grants from the National Institute on Aging, the US Department of Health & Human Services (NIH/NIAID grant 1U01AI180158-01) and Hevolution.
Author information
Authors and Affiliations
Contributions
S.L. conceptualized, wrote and revised the Perspective. E.V. and M.S.-K. oversaw the writing and revision of this Perspective. J.R.P., A.A., G.C. and V.N.G. contributed to revising the manuscript and provided critical feedback.
Corresponding author
Ethics declarations
Competing interests
G.C. declares potential conflicts of interest related to companies involved in transplantation and aging, including eGenesis, Qihan, GC Therapeutics, Cellino, Rejuvenate Bio and Thymmune (further interests, outside of the scope of the current work, can be found in the Supplementary Note). A.A. declares a potential conflict of interest with Precise Bio, related to the bioprinting of human corneas. S.L., J.R.P., V.N.G., M.S.‑K. and E.V. have no competing interests.
Peer review
Peer review information
Nature Aging thanks Marius Wernig, Paolo De Simone, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Note
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lore, S., Poganik, J.R., Atala, A. et al. Replacement as an aging intervention. Nat Aging 5, 750–764 (2025). https://doi.org/10.1038/s43587-025-00858-6
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s43587-025-00858-6